Cargando…

The Clinical Efficacy of Mometasone Furoate in Multi-Lamellar Emulsion for Eczema: A Double-blinded Crossover Study

BACKGROUND: Topical application of corticosteroids also has an influence on skin barrier impairment. Physiological lipid mixtures, such as multi-lamellar emulsion (MLE) containing a natural lipid component leads to effective recovery of the barrier function. OBJECTIVE: The purpose of this study was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Duk Han, Lee, Hyun Jong, Park, Chun Wook, Kim, Kyu Han, Lee, Kwang Hoon, Ro, Byung In, Cho, Sang Hyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Dermatological Association; The Korean Society for Investigative Dermatology 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3582923/ https://www.ncbi.nlm.nih.gov/pubmed/23467551 http://dx.doi.org/10.5021/ad.2013.25.1.17

Ejemplares similares

Efficacy of mometasone furoate and fluticasone furoate on persistent allergic rhinoconjunctivitis
por: Aneeza, W. Hamizan, et al.
Publicado: (2013)

Mometasone furoate in the management of asthma: a review
por: Tan, Ricardo A, et al.
Publicado: (2008)

Effectiveness of calamine lotion as an adjunctive therapy to mometasone furoate ointment in the treatment of infant eczema: A retrospective study
por: Meng, Yuan-Cui, et al.
Publicado: (2022)

Effectiveness of 0.1% mometasone furoate under hydrocolloid dressing versus 0.1% mometasone furoate in patients with lichen simplex chronicus
por: Lo, Hiu Lai, et al.
Publicado: (2023)

Mometasone furoate nasal spray: a systematic review
por: Passali, Desiderio, et al.
Publicado: (2016)

Mometasone furoate is not superior to saline for chronic rhinitis in the elderly
por: Carvalho, Victor, et al.
Publicado: (2019)

Nasal Absorption Enhancement of Mometasone Furoate Nanocrystal Dispersions
por: Masuda, Shuya, et al.
Publicado: (2023)

Zein nanoparticles as oral carrier for mometasone furoate delivery
por: Zimath, Priscila, et al.
Publicado: (2023)

Comparison of the systemic bioavailability of mometasone furoate after oral inhalation from a mometasone furoate/formoterol fumarate metered-dose inhaler versus a mometasone furoate dry-powder inhaler in patients with chronic obstructive pulmonary disease
por: Kosoglou, Teddy, et al.
Publicado: (2013)

Development of simple and fast UV-method for the quantitative determination of mometasone furoate in a large number of metered doses of an aqueous nasal spray of mometasone furoate
por: Levin, Mykhaylo, et al.
Publicado: (2019)

Efficacy and Safety Evaluation of Mometasone Furoate in Treating Ocular Inflammation
por: Lage, Nayara Almeida, et al.
Publicado: (2023)

Suppression of Cytokine Release by Fluticasone Furoate vs. Mometasone Furoate in Human Nasal Tissue Ex-Vivo
por: Zhang, Nan, et al.
Publicado: (2014)

A patient preference study that evaluated fluticasone furoate and mometasone furoate nasal sprays for allergic rhinitis
por: Yanez, Anahi, et al.
Publicado: (2016)

Mometasone furoate and fluticasone furoate are equally effective in restoring nasal epithelial barrier dysfunction in allergic rhinitis
por: Doulaptsi, Maria, et al.
Publicado: (2021)

Significant receptor affinities of metabolites and a degradation product of mometasone furoate
por: Valotis, Anagnostis, et al.
Publicado: (2004)

One-year treatment with mometasone furoate in chronic obstructive pulmonary disease
por: Calverley, Peter MA, et al.
Publicado: (2008)

Development and evaluation of solid lipid nanoparticles of mometasone furoate for topical delivery
por: Madan, Jyotsana R, et al.
Publicado: (2014)

Comparative safety and efficacy of topical mometasone furoate with other topical corticosteroids
por: Spada, Fabrizio, et al.
Publicado: (2018)

Effects of intranasal mometasone furoate on blood pressure in patients with allergic rhinitis
por: Kartal, O., et al.
Publicado: (2018)

New Vehiculation Systems of Mometasone Furoate for the Treatment of Inflammatory Skin Diseases
por: Taléns-Visconti, Raquel, et al.
Publicado: (2022)

Effect of once-daily indacaterol maleate/mometasone furoate on exacerbation risk in adolescent and adult asthma: a double-blind randomised controlled trial
por: Beasley, Richard W, et al.
Publicado: (2015)

Efficacy of mometasone furoate for nasal polyps: A protocol for systematic review of randomized controlled trial
por: Yu, Hai-jiang, et al.
Publicado: (2019)

TRIPLE COMBINATION OF HYDROQUINONE, TRETINOIN AND MOMETASONE FUROATE WITH GLYCOLIC ACID PEELS IN MELASMA
por: Godse, Kiran V
Publicado: (2009)

Use of tiotropium bromide in an adolescent with adrenal suppression secondary to inhaled mometasone furoate
por: Hanna, Mariam, et al.
Publicado: (2014)

Developing Biodegradable Nanoparticles Loaded with Mometasone Furoate for Potential Nasal Drug Delivery
por: Far, Jumana, et al.
Publicado: (2020)

Mometasone Furoate in Non-Allergic Rhinitis: A Real-Life Italian Study
por: Rizzi, Angela, et al.
Publicado: (2022)

Long-term safety of Mometasone Furoate administered via a dry powder inhaler in children: Results of an open-label study comparing Mometasone Furoate with Beclomethasone Dipropionate in children with persistent asthma
por: Noonan, Michael, et al.
Publicado: (2009)

In-office Placement of Mometasone Furoate Sinus Implants for Recurrent Nasal Polyps: A Pooled Analysis
por: Stolovitzky, J. Pablo, et al.
Publicado: (2019)

Effect of mometasone furoate/formoterol combination therapy on nocturnal awakenings in subjects with persistent asthma
por: Pearlman, David, et al.
Publicado: (2011)

Long-Term Safety of Mometasone Furoate/Formoterol Combination for Treatment of Patients with Persistent Asthma
por: Maspero, Jorge F, et al.
Publicado: (2010)

The efficacy of mometasone furoate for children with asthma: a meta-analysis of randomized controlled trials
por: Song, Yanling, et al.
Publicado: (2020)

Lung Function Normalisation with Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate in Patients with Asthma
por: Chapman, Kenneth R., et al.
Publicado: (2021)

Mometasone furoate nasal spray in the treatment of patients with COVID-19 olfactory dysfunction: A randomized, double blind clinical trial
por: Kasiri, Hossein, et al.
Publicado: (2021)

A phase 3 trial of mometasone furoate sinus implants for chronic sinusitis with recurrent nasal polyps
por: Kern, Robert C., et al.
Publicado: (2018)

Inhaled mometasone furoate for the management of refractory oral corticosteroid-dependent asthma: a case report
por: Nsouli, Talal M
Publicado: (2009)

Efficacy and safety of combined medium-dose mometasone furoate/formoterol (MF/F) in persistent asthmatics
por: Nathan, Robert A, et al.
Publicado: (2010)

Assessment of Patient Attitudes About Mometasone Furoate Nasal Spray: The Ease-of-Use Patient Survey
por: Fromer, Leonard M, et al.
Publicado: (2008)

190 Effect of Mometasone Furoate/Formoterol Combination Therapy on Nocturnal Awakenings in Subjects With Persistent Asthma
por: Pearlman, David, et al.
Publicado: (2012)

191 Quality of Life Improvements in Persistent Asthma Subjects Receiving Combined Mometasone Furoate and Formoterol
por: Murphy, Kevin, et al.
Publicado: (2012)

The glucocorticoid mometasone furoate is a novel FXR ligand that decreases inflammatory but not metabolic gene expression
por: Bijsmans, Ingrid T. G. W., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_siclrqrkihaupf4stgtbru096b